Literature DB >> 35578088

Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update.

Partha Roy1, Srija Sur2, Suvadra Das3, Wong Tin Wui4.   

Abstract

Breast cancer is the most common malignancy in women and is rated among one of the three common malignancies worldwide in combination with colon and lung cancer. The escalating mortality rate of breast cancer patients has captivated the attention of the present-day researchers to come up with new management options. According to WHO, early detection, timely diagnosis and comprehensive breast cancer management are the three cornerstones for controlling breast cancer incidences per year. Multidisciplinary theragnostic approaches for simultaneous diagnosis and treatment of breast cancer have further enriched the therapeutic arsenal. Imaging and biopsy play a significant role in the diagnosis of breast cancer. The treatment plan mostly initiates with general surgery or radiation therapy followed up with adjuvant and/or neoadjuvant therapy. Conventional chemotherapeutics in breast cancer suffer from toxicity and lack of site specificity. Bio-safe gold nanoparticles hold sufficient promise for bridging this gap. Diverse phytochemicals-based synthesis routes to arrive at nano-dimensional gold with spotlight on reaction mechanisms, reaction variables, specific advantages, toxicity and their influence in breast cancer conditions are the focus of this work. This review marks the first attempt to explore the potential of phytochemical-derived nano-gold in breast cancer treatment.
© 2022. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Entities:  

Keywords:  Bio-safe; Breast cancer; Gold nanoparticle; Phytochemicals; Theragnostic

Mesh:

Substances:

Year:  2022        PMID: 35578088     DOI: 10.1007/s12282-022-01368-8

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   3.307


  55 in total

1.  Gold nanoparticles exposure modulates antioxidant and innate immune gene expression in the gills of Sparus aurata.

Authors:  Pinanong Na-Phatthalung; Mariana Teles; Lluís Tort; Miguel Oliveira
Journal:  Genomics       Date:  2018-10-27       Impact factor: 5.736

Review 2.  Carotenoids.

Authors:  Billy R Hammond; Lisa M Renzi
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

3.  Andrographolide engineered gold nanoparticle to overcome drug resistant visceral leishmaniasis.

Authors:  Suvadra Das; Asim Halder; Saptarshi Mandal; Mohammad Abu Jafar Mazumder; Tanmoy Bera; Arup Mukherjee; Partha Roy
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-02-08       Impact factor: 5.678

Review 4.  New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.

Authors:  Priscila Falagan-Lotsch; Elissa M Grzincic; Catherine J Murphy
Journal:  Bioconjug Chem       Date:  2017-01-04       Impact factor: 4.774

5.  Antiangiogenic properties of gold nanoparticles.

Authors:  Priyabrata Mukherjee; Resham Bhattacharya; Ping Wang; Ling Wang; Sujit Basu; Janice A Nagy; Anthony Atala; Debabrata Mukhopadhyay; Shay Soker
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

Review 6.  Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Authors:  Jihyoun Lee; Dev Kumar Chatterjee; Min Hyuk Lee; Sunil Krishnan
Journal:  Cancer Lett       Date:  2014-02-17       Impact factor: 8.679

7.  Breast Cancer Treatment.

Authors:  Adrienne G Waks; Eric P Winer
Journal:  JAMA       Date:  2019-01-22       Impact factor: 56.272

Review 8.  Carotenoids: Potent to Prevent Diseases Review.

Authors:  Takshma Bhatt; Kirtan Patel
Journal:  Nat Prod Bioprospect       Date:  2020-05-13

9.  Carotenoids and total phenolic contents in plant foods commonly consumed in Korea.

Authors:  Gun-Ae Yoon; Kyung-Jin Yeum; Yoon-Suk Cho; C-Y Oliver Chen; Guangwen Tang; Jeffrey B Blumberg; Robert M Russell; Sun Yoon; Yang Cha Lee-Kim
Journal:  Nutr Res Pract       Date:  2012-12-31       Impact factor: 1.926

10.  Cancer Statistics, 2020: Report From National Cancer Registry Programme, India.

Authors:  Prashant Mathur; Krishnan Sathishkumar; Meesha Chaturvedi; Priyanka Das; Kondalli Lakshminarayana Sudarshan; Stephen Santhappan; Vinodh Nallasamy; Anish John; Sandeep Narasimhan; Francis Selvaraj Roselind
Journal:  JCO Glob Oncol       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.